Tuesday, 26 March 2013

New Frontiers in Cell Line Development and Opportunities for Biosimilars

Conference Description
Key Speakers Include:-

Arun Bhatt, President, Clininvent Research 
R. H. Jani, Senior Vice President, Clinical R&D, Cadila
Purnima Sharma, Managing Director, Biotech Consortium India Limited BCIL
Annaswamy Vaidheesh, Vice President- Government affairs Asia Pacific, Johnson & Johnson
Bobby George, Asssitant Vice President and Head, Regulatory Affairs, Reliance Life Sciences
Dilip Pawar, Director and Head Clinical Development, Dr Reddys
Kaustubh Berde, Vice President & Head - International Formulations, Panacea Biotec
Yatin Gokarn, Narotam Sekhsaria Distinguished Professor of Chemical Engineering, Institute of Chemical Technology.
(Former Associate Director, Genentech (San Francisco)
Anurita Majumdar, Director - Medical & Regulatory - India & South Africa, Eli Lilly
Chirag Trivedi, Associate Director - Project Management & Strategic Initiatives, Sanofi-Aventis
Kedar Suvarnapathaki, Head - Regulatory Affair, Boehringer Ingelheim
Yasmin Shenoy, Director-Regulatory Affairs, Sanofi-Aventis
Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates
Plus Many More...

The recent establishment of regulatory guidelines for biosimilars in India is expected to add further momentum to the growth of the global biosimilars market. Increasing pressure from governments and insurers for greater biologic competition, there exists an incredible opportunity for biosimilar producers to capitalise on what is set to become the fastest growing sector of the pharmaceutical industry. Due to the limited clinical database at the time of approval of a biosimilar, vigorous pharmacovigilance is required. & Biosimilars are set to become an important part of the future medicines market.

To know more about conferences on : 

3rd Biosimilars Congregation 2013

Thursday, 21 March 2013

Breathe Technologies, Inc. - Medical Equipment Company

Breathe Technologies, Inc. (Breathe Technologies) is a health-care solutions provider, based in the US. The company develops and manufactures the therapeutic respiratory systems. The respiratory systems are useful to patients of various respiratory illnesses such as emphysema, chronic bronchitis, cystic fibrosis, influenza, among other respiratory conditions that limit normal breathing. Its products include ultra lightweight, compact, wearable mobile ventilator system that helps during breathing problems and is useful for heart – patients. The company develops solutions for empowering healthcare providers and patients with reliable and accessible respiratory therapies that optimize breathing and mobility. Breathe Technologies is headquartered in San Ramon, California, the US.

Breathe Technologies, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. 

To know more about : Breathe Technologies, Inc

Wednesday, 20 March 2013

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile

Smith & Nephew, Inc. is a medical device company. It carries out the development, manufacture and marketing of medical devices. The company manufactures orthopedic reconstruction and trauma, endoscopy, and advanced wound management equipment. It offers its products for surgeons and hospitals. The company is a subsidiary of Smith & Nephew Plc. Smith & Nephew, Inc is headquartered in Memphis, Tennessee, the US.

Smith & Nephew, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

To know more :  Smith & Nephew, Inc